News | May 03, 2023
CPHI & PMEC China 2023 to see surge from pent up international ingredients demand
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
China recorded unprecedented improvement in its API manufacturing score in the 2022 end of year CPHI Survey
The company will respond to these observations within the stipulated time period.
Surana is a chartered accountant with an all-India rank.
The revenues and profits derived from the new subsidiary will be consolidated in the parent company
The US FDA has closed the observations pertaining to this audit with an Establishment Inspection Report on the 20th of July 2021
The company will provide one crore tablets every week, starting from 12th May 2021, aggregating to 16 crore tablets worth Rs. 8 crores over the next 4 months
Biocon Pharma will be responsible for drug development and manufacturing, while Libbs will leverage its deep expertise and reach in Brazil to import, distribute and market
Subscribe To Our Newsletter & Stay Updated
